Analysis
of blood clot degradation fragment sizes in relation to plasma flow
velocity. |
|
Bajd
F, Vidmar J, Blinc A, Sera I. |
237-245 |
|
|
Effect
of lesions of A5 or A7 noradrenergic cell group or surgical
transection of brainstem catecholamine pathways on plasma
catecholamine levels in rats injected subcutaneously by formalin. |
247-254 |
Mravec
B, Bodnar I, Uhereczky G, Kvetnansky R, Palkovits M. |
|
|
|
Role
of fenofibrate in restoring angiogenesis in diabetic and control
hind limb ischemic rats. |
255-260 |
Salehi
E, Khazaei M, Rashidi B. |
|
|
|
Prolonged
oxytocin treatment in rats affects intracellular signaling and
induces myocardial protection against infarction. |
261-270 |
Ondrejcakova
M, Barancik M, Bartekova M, Ravingerova T, Jezova D. |
|
|
|
The
influence of ETA and ETB receptor blockers on LPS-induced oxidative
stress and NF-κB signaling pathway in heart. |
271-278 |
Piechota-Polanczyk
A, Kleniewska P, Gorąca A. |
|
|
|
Reactivity
of the mesenteric bed arteries of normotensive rats exposed to
chronic social stress. |
279-290 |
Puzserova
A, Torok J, Sotnikova R, Zemancikova A, Bernatova I. |
|
|
|
Song-related
dopamine receptor regulation in Area X of zebra finch male. |
291-298 |
Bosíková
E, Koťál Ľ, Cviková M, Bilčík B, Niederová-Kubíková
Ľ. |
|
|
|
The
effects of REV5901 on intracellular calcium signalling in freshly
isolated bovine articular chondrocytes. |
299-307 |
Qusous
A, Parker E, Ali N, Mohmand SG, Kerrigan MJ. |
|
|
|
Promoter-context
as a determinant of glucocorticoid receptor-responsiveness to
activation of p38 and JNK mitogen-activated protein (MAP) kinases. |
309-322 |
Szatmary
Z, Kebis A. |
|
|
|
Ursolic
acid and rosiglitazone combination alleviates metabolic syndrome in
high fat diet fed C57BL/6J mice. |
323-333 |
Sundaresan
A, Harini R, Pugalendi KV. |
|
|
|
Evaluation
of Opuntia ficus indica f. inermis fruit juice hepatoprotective
effect upon ethanol toxicity in rats. |
335-342 |
Alimi
H, Hfaeidh N, Mbarki S, Bouoni Z, Sakly M, Ben Rouma K. |
|
|
|
The
activity of G-ROS and the predominant role of Type II reaction in
the photodynamic therapy using 9-hydroxypheophorbide-α for HeLa
cell lines. |
343-350 |
Ahn
JC, Chung PS. |
|
|
|
|
|
|
|
|
|
|
|
|
|